Gene Therapy Trial for Otoferlin Gene-mediated Hearing Loss

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Sensorineural Hearing Loss, Bilateral

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
Study leads
  • Peter Marks, MD

    Study Director

    Eli Lilly and Company